11 – 20 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer
- Contribution to journal › Article
-
Mark
Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils
- Contribution to journal › Article
-
Mark
Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique Pocket
- Contribution to journal › Article
-
Mark
Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of Cancer
- Contribution to journal › Article
-
Mark
Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver
- Contribution to journal › Article
-
Mark
Sulfonamide-derivatized galactosides selectively target an unexplored binding site in the galectin-9N-terminal domain
- Contribution to journal › Article
-
Mark
Myocardin related transcription factor and galectin-3 drives lipid accumulation in human blood vessels
- Contribution to journal › Article
- 2023
-
Mark
Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1
- Contribution to journal › Article
-
Mark
Ligand Sulfur Oxidation State Progressively Alters Galectin-3-Ligand Complex Conformations To Induce Affinity-Influencing Hydrogen Bonds
- Contribution to journal › Article
-
Mark
Discovery of Selective and Orally Available Galectin-1 Inhibitors
- Contribution to journal › Article
